| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Improved rate of screening and recognition of elevated BP |
| Risks, harm, cost | Cost of EHR development, alert fatigue |
| Benefit–harm assessment | Benefit of EHR flagging of elevated BP outweighs harm from development cost and potential for alert fatigue |
| Intentional vagueness | None |
| Role of patient preferences | None |
| Exclusions | None |
| Strength | Weak recommendation (because of a lack of pediatric data) |
| Key references | 7,117,120,125 |
| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Improved rate of screening and recognition of elevated BP |
| Risks, harm, cost | Cost of EHR development, alert fatigue |
| Benefit–harm assessment | Benefit of EHR flagging of elevated BP outweighs harm from development cost and potential for alert fatigue |
| Intentional vagueness | None |
| Role of patient preferences | None |
| Exclusions | None |
| Strength | Weak recommendation (because of a lack of pediatric data) |
| Key references | 7,117,120,125 |